A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake
- PMID: 9688880
- DOI: 10.1152/ajpendo.1998.275.1.E101
A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake
Abstract
The effect of a negative arterial-portal venous (a-pv) glucose gradient on skeletal muscle and whole body nonhepatic glucose uptake was studied in 12 42-h-fasted conscious dogs. Each study consisted of a 110-min equilibration period, a 30-min baseline period, and two 120-min hyperglycemic (2-fold basal) periods (either peripheral or intraportal glucose infusion). Somatostatin was infused along with insulin (3 x basal) and glucagon (basal). Catheters were inserted 17 days before studies in the external iliac artery and hepatic, portal and common iliac veins. Blood flow was measured in liver and hindlimb using Doppler flow probes. The arterial blood glucose, arterial plasma insulin, arterial plasma glucagon, and hindlimb glucose loads were similar during peripheral and intraportal glucose infusions. The a-pv glucose gradient (in mg/dl) was 5 +/- 1 during peripheral and -18 +/- 3 during intraportal glucose infusion. The net hindlimb glucose uptakes (in mg/min) were 5.0 +/- 1.2, 20.4 +/- 4.5, and 14.8 +/- 3.2 during baseline, peripheral, and intraportal glucose infusion periods, respectively (P < 0.01, peripheral vs. intraportal); the hindlimb glucose fractional extractions (in %) were 2.8 +/- 0.4, 4.7 +/- 0.8, and 3.9 +/- 0.5 during baseline, peripheral, and intraportal glucose infusions, respectively (P < 0. 05, peripheral vs. intraportal). The net whole body nonhepatic glucose uptakes (in mg . kg-1 . min-1) were 1.6 +/- 0.1, 7.9 +/- 1.3, and 5.4 +/- 1.1 during baseline, peripheral, and intraportal glucose infusion, respectively (P < 0.05, peripheral vs. intraportal). In the liver, net glucose uptake was 70% greater during intraportal than during peripheral glucose infusion (5.8 +/- 0.7 vs. 3.4 +/- 0.4 mg . kg-1 . min-1). In conclusion, despite comparable glucose loads and insulin levels, hindlimb and whole body net nonhepatic glucose uptake decreased significantly during portal venous glucose infusion, suggesting that a negative a-pv glucose gradient leads to an inhibitory signal in nonhepatic tissues, among which skeletal muscle appears to be the most important.
Similar articles
-
Importance of the hepatic arterial glucose level in generation of the portal signal in conscious dogs.Am J Physiol Endocrinol Metab. 2000 Aug;279(2):E284-92. doi: 10.1152/ajpendo.2000.279.2.E284. Am J Physiol Endocrinol Metab. 2000. PMID: 10913027
-
Role of a negative arterial-portal venous glucose gradient in the postexercise state.Am J Physiol. 1999 Dec;277(6):E1038-45. doi: 10.1152/ajpendo.1999.277.6.E1038. Am J Physiol. 1999. PMID: 10600793
-
A negative arterial-portal venous glucose gradient increases net hepatic glucose uptake in euglycemic dogs.Am J Physiol. 1999 Jul;277(1):E126-34. doi: 10.1152/ajpendo.1999.277.1.E126. Am J Physiol. 1999. PMID: 10409136
-
Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo.Diabetes. 1999 May;48(5):1198-214. doi: 10.2337/diabetes.48.5.1198. Diabetes. 1999. PMID: 10331429 Review. No abstract available.
-
Regulation of net hepatic glucose uptake: interaction of neural and pancreatic mechanisms.Reprod Nutr Dev. 1996;36(4):399-406. doi: 10.1051/rnd:19960406. Reprod Nutr Dev. 1996. PMID: 8878357 Review.
Cited by
-
Hepatic interoception in health and disease.Auton Neurosci. 2024 Jun;253:103174. doi: 10.1016/j.autneu.2024.103174. Epub 2024 Mar 29. Auton Neurosci. 2024. PMID: 38579493 Review.
-
Hepatocyte membrane potential regulates serum insulin and insulin sensitivity by altering hepatic GABA release.Cell Rep. 2021 Jun 29;35(13):109298. doi: 10.1016/j.celrep.2021.109298. Cell Rep. 2021. PMID: 34192533 Free PMC article.
-
Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model.Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E133-E145. doi: 10.1152/ajpendo.00479.2019. Epub 2020 May 27. Am J Physiol Endocrinol Metab. 2020. PMID: 32459527 Free PMC article.
-
MetAP2 inhibitor treatment of high-fat and -fructose-fed dogs: impact on the response to oral glucose ingestion and a hyperinsulinemic hyperglycemic clamp.Am J Physiol Endocrinol Metab. 2020 Apr 1;318(4):E514-E524. doi: 10.1152/ajpendo.00451.2019. Epub 2020 Jan 28. Am J Physiol Endocrinol Metab. 2020. PMID: 31990576 Free PMC article.
-
Sympathetic Denervation of the Common Hepatic Artery Lessens Glucose Intolerance in the Fat- and Fructose-Fed Dog.Diabetes. 2019 Jun;68(6):1143-1155. doi: 10.2337/db18-1209. Epub 2019 Apr 1. Diabetes. 2019. PMID: 30936143 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous